[Premature ejaculation: pills or sexology?].

Area of Science:

• Urology
• Andrology
• Sexual Medicine

Context:

• Premature ejaculation (PE) is a prevalent male sexual dysfunction, impacting 20-30% of the male population.
• The etiology of PE remains multifactorial, with proposed psychological, behavioral, and biological origins.

Purpose:

• To review the current understanding and treatment modalities for premature ejaculation (PE).
• To evaluate the efficacy and limitations of selective serotonin reuptake inhibitors (SSRIs) in PE management.
• To discuss alternative approaches like the sexocorporal method.

Summary:

• Selective serotonin reuptake inhibitors (SSRIs) have emerged as a significant pharmacological intervention for PE.
• Potential adverse effects of SSRIs necessitate careful consideration in treatment protocols.
• Long-term efficacy and the potential for a permanent cure with SSRIs are not yet established.
• The sexocorporal approach is an alternative, but lacks robust scientific evidence.

Impact:

• Highlights the need for further research into the etiology and optimal treatment of PE.
• Informs clinicians and patients about the benefits and risks associated with SSRI treatment for PE.
• Underscores the current gaps in evidence for non-pharmacological PE interventions.